Home › Venous Thromboembolism › Texas
Venous Thromboembolism clinical trials in Texas
7 studies for Venous Thromboembolism are looking for participants at sites in Texas.
Cities in Texas
REGN7508 in Adult Participants for Prevention of Cancer-Associated Thrombosis
- El Paso Medical Research Institute (Medresearch Inc), El Paso
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 29, 2026 · NCT07410117REGN7508 Versus Apixaban and Enoxaparin for Thromboprophylaxis After Total Knee Arthroplasty in Adults
- HD Research - First Surgical Hospital, Bellaire
- University of Texas (UT); Southwestern Medical Center, Dallas
- NextStage Clinical Research, All American Orthopedics and Sports Medicine, Houston
- and 3 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT07015905Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation for Whom Oral Anticoagulation is Unsuitable
- PharmaTex Research, Amarillo
- PanAmerican Clinical Research, Brownsville
- Southwest Family Medicine Associates, Dallas
- and 6 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 17, 2026 · NCT07430956Statins to Prevent Cancer Associated Blood Clots
- The University of Texas MD Anderson Cancer Center, Houston
RecruitingPhase 4
Ages 18 and older · All sexes · Updated Sep 16, 2026 · NCT07303816DEFIANCE: RCT of ClotTriever System Versus Anticoagulation In Deep Vein Thrombosis
- Clements University Hospital (UTSW), Dallas
Recruiting
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT05701917Cleaner Long-tErm Assessment Registry - Venous Insights and Efficacy With eXtended Tracking
- Baylor Scott & White The Heart Hospital - Plano, Plano
RecruitingObservational study
Ages 18 and older · All sexes · Updated Jun 16, 2026 · NCT07102160Catheter-Related Early Thromboprophylaxis With Enoxaparin Studies
- Dell Children's Medical Canter, Austin
- UTSW Medical Center; Children's Medical Center of Dallas, Dallas
RecruitingPhase 2/3
Up to age 17 · All sexes · Updated Jun 8, 2026 · NCT04924322From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.